Warrant
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 40 of Werewolf Therapeutics, Inc.'s SEC filings and found 2 warrant series, 1 convertible, 1 ATM program, 1 shelf registration and 1 completed offering on file for HOWL. Analysis updated Oct 7, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 74 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 21, 2026 · Offering Priced
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Issued 2022
Total capacity
Sold to date
Issued 2025
Total capacity
Remaining
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z